• KO
  • EN
logo
  • Biostar
    • 技术研究院介绍
    • 发展历史
    • 组织结构
    • 干细胞介绍
    • Biostar 干细胞优势
  • 研究
    • 技术专利
    • 发表论文
    • 动物临床试验
    • 研究人员临床试验
  • 干细胞治疗剂
    • Joint Stem
    • VascoStem
    • AstroStem
  • 合作伙伴
  • 新闻
  • 联系我们
  • Biostar
    • 技术研究院介绍
    • 发展历史
    • 组织结构
    • 干细胞介绍
    • Biostar 干细胞优势
  • 研究
    • 技术专利
    • 发表论文
    • 动物临床试验
    • 研究人员临床试验
  • 干细胞治疗剂
    • Joint Stem
    • VascoStem
    • AstroStem
  • 合作伙伴
  • 新闻
  • 联系我们

免疫系统

  • Home
  •  
  • 免疫系统
    • 2015-04-07

    Transplantation of CTLA4Ig gene-transduced adipose tissue-derived mesenchymal stem cells reduces inflammatory immune response and improves Th1/Th2 balance in experimental autoimmune thyroiditis.

    BACKGROUND:Autoimmune thyroiditis is one of common organ-specific autoimmune disease. The aim of this study was to observe the effect of adipose tissue derived mesenchymal stem cells (ATMSC) and CTLA4Ig gene-transduced ATMSC on autoimmune thyroiditis.
    METHODS:Experimental autoimmune thyroiditis was induced by immunization with thyroglobulin. Animals were divided into three groups: (i) a half million of human ATMSC, (ii) a half million of murine CLTA4Ig gene-transduced human ATMSC (CTLA4Ig-MSC), or (iii) normal saline (as control), which were administered intravenously four times within a 3-week period. Blood and tissue samples were collected 1 week after the last cell transplantation.

    Read more
    • Biostar干细胞技术研究院
    • Comments: 0
    • 2015-04-07

    Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells

    Prolonged life expectancy, life style and environmental changes have caused a changing disease pattern in developed countries towards an increase of degenerative and autoimmune diseases. Stem cells have become a promising tool for their treatment by promoting tissue repair and protection from immune-attack associated damage. Patient-derived autologous stem cells present a safe option for this treatment since these will not induce immune rejection and thus multiple treatments are possible without any risk for allogenic sensitization, which may arise from allogenic stem cell transplantations.

    Read more
    • Biostar干细胞技术研究院
    • Comments: 0

最多评论

  • K-STEM CELL 干细胞技术,踏出第一步抢占日本再生医疗。 5 2015-03-12
  • K-STEM CELL,利用干细胞促进软骨再生尚属世界首例。 3 2014-03-06
  • (株)Biostar Korea,获得食品医药品安全处CGMP型企业认证。 1 2014-04-25

最受欢迎

  • K-STEM CELL,利用干细胞促进软骨再生尚属世界首例。 4305 2014-03-06
  • Nature cell“Dr.Jucre面膜”正式出口到中国 4259 2017-03-13
  • K-STEM CELL 干细胞技术,踏出第一步抢占日本再生医疗。 3522 2015-03-12
  • (株)Biostar Korea,获得食品医药品安全处CGMP型企业认证。 2891 2014-04-25
  • VASCOSTEM和Joint Stem进展情况新闻发布会 2830 2015-09-02
  • 联系我们

  • 标签

  • 家族网站


Biostar干细胞技术研究院

(邮编)153-768
韩国首尔市衿川区
加山数码园区2路98号, 2幢305室
株)R Bio
公司电话 : +82 -2-858-8021~5

태그

Dr.Jucre Joint Stem LaStem Swiss Nature Cell R Bio VASCOSTEM 专利 世界第一 伯格氏病 关节炎 干细胞 干细胞培养液化妆品 成体干细胞 是退行性关节炎 皮肤再生 罕见疑难病 老年性痴呆症 胎盘干细胞 脑瘫 软骨再生 退行性关节炎
  • - Biostar
  • - R Bio
  • - Nature Cell
  • - Brain Cell
  • - JASC
  • - Stemcell Life Foundation
  • - GDFI Braincell
  • - Bethesda Hospital
  • - Biostar Asia
  • - Cafe Trinity
© Biostar干细胞研发中心2017年版权所有
Scroll